BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35102266)

  • 1. Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome.
    Barandouzi ZA; Lee J; Del Carmen Rosas M; Chen J; Henderson WA; Starkweather AR; Cong XS
    Sci Rep; 2022 Jan; 12(1):1648. PubMed ID: 35102266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
    Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Role of Vitamin D and the Gut Microbiome: A Cross-Sectional Study of Individuals with Irritable Bowel Syndrome and Healthy Controls.
    Matthews SW; Plantinga A; Burr R; Cain KC; Savidge T; Kamp K; Heitkemper MM
    Biol Res Nurs; 2023 Jul; 25(3):436-443. PubMed ID: 36624571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
    Peter J; Fournier C; Keip B; Rittershaus N; Stephanou-Rieser N; Durdevic M; Dejaco C; Michalski M; Moser G
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
    Kim GH; Lee K; Shim JO
    Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gut microbiota of iranian patients with celiac disease, non-celiac wheat sensitivity, and irritable bowel syndrome: are there any similarities?
    Naseri K; Dabiri H; Olfatifar M; Shahrbaf MA; Yadegar A; Soheilian-Khorzoghi M; Sadeghi A; Saadati S; Rostami-Nejad M; Verma AK; Zali MR
    BMC Gastroenterol; 2023 Jan; 23(1):15. PubMed ID: 36647022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile Acids and Microbiome Among Individuals With Irritable Bowel Syndrome and Healthy Volunteers.
    Kamp KJ; Cain KC; Utleg A; Burr RL; Raftery D; Luna RA; Shulman RJ; Heitkemper MM
    Biol Res Nurs; 2021 Jan; 23(1):65-74. PubMed ID: 32666807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
    J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome.
    Mujagic Z; Kasapi M; Jonkers DM; Garcia-Perez I; Vork L; Weerts ZZRM; Serrano-Contreras JI; Zhernakova A; Kurilshikov A; Scotcher J; Holmes E; Wijmenga C; Keszthelyi D; Nicholson JK; Posma JM; Masclee AA
    Gut Microbes; 2022; 14(1):2063016. PubMed ID: 35446234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.
    Zeber-Lubecka N; Kulecka M; Ambrozkiewicz F; Paziewska A; Goryca K; Karczmarski J; Rubel T; Wojtowicz W; Mlynarz P; Marczak L; Tomecki R; Mikula M; Ostrowski J
    Gut Microbes; 2016 Sep; 7(5):397-413. PubMed ID: 27662586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome.
    Goll R; Johnsen PH; Hjerde E; Diab J; Valle PC; Hilpusch F; Cavanagh JP
    Gut Microbes; 2020 Nov; 12(1):1794263. PubMed ID: 32991818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric Microbiota-Mediated Serotonergic Signaling in Pathogenesis of Irritable Bowel Syndrome.
    Mishima Y; Ishihara S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome.
    Peter J; Fournier C; Durdevic M; Knoblich L; Keip B; Dejaco C; Trauner M; Moser G
    Psychosom Med; 2018 Oct; 80(8):698-709. PubMed ID: 30095672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methanogen Levels Are Significantly Associated with Fecal Microbiota Composition and Alpha Diversity in Healthy Adults and Irritable Bowel Syndrome Patients.
    Wang T; van Dijk L; Rijnaarts I; Hermes GDA; de Roos NM; Witteman BJM; de Wit NJW; Govers C; Smidt H; Zoetendal EG
    Microbiol Spectr; 2022 Dec; 10(6):e0165322. PubMed ID: 36321894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
    De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
    Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.